---
figid: PMC8526300__JIR-14-5251-g0001
figtitle: New Horizons for the Roles and Association of APE1/Ref-1 and ABCA1 in Atherosclerosis
organisms:
- Mus musculus
- Rattus norvegicus
- Homo sapiens
- Coxsackievirus B3
pmcid: PMC8526300
filename: JIR-14-5251-g0001.jpg
figlink: /pmc/articles/PMC8526300/figure/f0001/
number: F1
caption: The mechanism of APE1/Ref-1 in atherosclerosis. APE1/Ref-1 has both proatherogenic
  and antiatherogenic effects. APE1/Ref-1 suppresses atherosclerosis via multiple
  mechanisms. APE1/Ref-1 reduces the proinflammatory response by increasing thiol–disulfide
  exchanges and suppressing the expression of IL-6, TNF-α, and IL-1β. APE1/Ref-1 reduces
  oxidant activity by suppressing ROS levels and decreases vascular calcification
  and apoptosis by suppressing the Bax/Bcl-2 ratio. APE1/Ref-1 reduces cholesterol
  uptake by binding OCT1 to inhibit activation of the LOX-1 promoter. APE1/Ref-1 decreases
  monocyte adhesion by suppressing superoxide production and p38 MAPK expression to
  restrain VCAM-1. APE1/Ref-1 reduces DNA damage and oxidative tissue injury. APE1/Ref-1
  promotes atherosclerosis via multiple mechanisms. APE1/Ref-1 increases the proinflammatory
  response by increasing NK-κB pathway signaling and TNF-α and MCP-1 expression. APE1/Ref-1
  promotes VSMC migration, apoptosis, and proliferation by binding the S1PR1 promoter.
papertitle: New Horizons for the Roles and Association of APE1/Ref-1 and ABCA1 in
  Atherosclerosis.
reftext: Wujun Chen, et al. J Inflamm Res. 2021;14:5251-5271.
year: '2021'
doi: 10.2147/JIR.S330147
journal_title: Journal of Inflammation Research
journal_nlm_ta: J Inflamm Res
publisher_name: Dove
keywords: atherosclerosis | inflammatory | APE1/Ref-1 | ABCA1 | cholesterol efflux
automl_pathway: 0.8827124
figid_alias: PMC8526300__F1
figtype: Figure
organisms_ner:
- Rattus norvegicus
- Homo sapiens
- Mus musculus
redirect_from: /figures/PMC8526300__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8526300__JIR-14-5251-g0001.html
  '@type': Dataset
  description: The mechanism of APE1/Ref-1 in atherosclerosis. APE1/Ref-1 has both
    proatherogenic and antiatherogenic effects. APE1/Ref-1 suppresses atherosclerosis
    via multiple mechanisms. APE1/Ref-1 reduces the proinflammatory response by increasing
    thiol–disulfide exchanges and suppressing the expression of IL-6, TNF-α, and IL-1β.
    APE1/Ref-1 reduces oxidant activity by suppressing ROS levels and decreases vascular
    calcification and apoptosis by suppressing the Bax/Bcl-2 ratio. APE1/Ref-1 reduces
    cholesterol uptake by binding OCT1 to inhibit activation of the LOX-1 promoter.
    APE1/Ref-1 decreases monocyte adhesion by suppressing superoxide production and
    p38 MAPK expression to restrain VCAM-1. APE1/Ref-1 reduces DNA damage and oxidative
    tissue injury. APE1/Ref-1 promotes atherosclerosis via multiple mechanisms. APE1/Ref-1
    increases the proinflammatory response by increasing NK-κB pathway signaling and
    TNF-α and MCP-1 expression. APE1/Ref-1 promotes VSMC migration, apoptosis, and
    proliferation by binding the S1PR1 promoter.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Bcl2
  - Bax
  - Olr1
  - Il6
  - Tnf
  - Il13
  - Mapk14
  - Vcam1
  - Apex1
  - Nfkb1
  - Ccl2
  - BCL2
  - BAX
  - OLR1
  - IL6
  - TNF
  - IL13
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - CRK
  - AIMP2
  - GRAP2
  - AHSA1
  - POLDIP2
  - VCAM1
  - APEX1
  - TEAD1
  - TFPI2
  - NFKB1
  - CCL2
  - Nkx3-1
  - Crk
  - Grap2
  - Syp
  - Ahsa1
  - Mcpt1
---
